ARVO names new officers

June 6, 2012
Ophthalmology Times Staff Reports

Peng T. Khaw, MD, PhD, FARVO, is the new president of the Association for Research in Vision and Ophthalmology (ARVO). He succeeds Jeffrey Boatright, PhD, FARVO, whose 1-year term ended in May.

Rockville, MD-Peng T. Khaw, MD, PhD, FARVO, is the new president of the Association for Research in Vision and Ophthalmology (ARVO). He succeeds Jeffrey Boatright, PhD, FARVO, whose 1-year term ended in May.

“I’m excited for the future of ARVO and honored to have the opportunity to play such a significant role in promoting its members and the field of ophthalmology and vision research in the coming year,” Dr. Khaw said.

He is director of the UK National Institute for Health Research Biomedical Research Centre of the Moorfields Eye Hospital NHS Foundation Trust and the University College London (UCL) Institute of Ophthalmology, professor at the UCL Institute of Ophthalmology, and a consultant ophthalmic surgeon at Moorfields Eye Hospital, London.

Dr. Khaw joins a new slate of officers and trustees. Jacob Pe’er, MD, FARVO, is vice president, and Craig E. Crosson, PhD, FARVO, is executive vice president.

Dr. Pe’er is professor and chairman of the department of ophthalmology at Hadassah-Hebrew University Medical Center and associate dean of Hebrew University-Hadassah Faculty of Medicine, Jerusalem. Dr. Crosson holds the Pawek-Vallotton Professor Endowed Chair and is a professor of ophthalmology and senior associate dean for research at the Medical University of South Carolina, Charleston.

The three new trustees serving 5-year terms on the ARVO board: Paul S. Bernstein, MD, PhD, FARVO, representing the biochemistry and molecular biology section; Emily Y. Chew, MD, FARVO, representing the clinical and epidemiologic research section; and Peter D. Lukasiewicz, PhD, representing the visual neuroscience section.

Dr. Bernstein is an associate professor of ophthalmology and visual sciences at the University of Utah School of Medicine, Salt Lake City. Dr. Chew is the deputy director of the division of epidemiology and clinical applications and the deputy clinical director at the National Eye Institute of the National Institutes of Health. Dr. Lukasiewicz is a professor and director of research in the department of ophthalmology and visual sciences and a professor in the department of anatomy and neurobiology at Washington University School of Medicine in St. Louis.

Justine Smith, MBBS, PhD, FARVO, has been named president-elect and will serve the 2013-to-2014 term. John S. Penn, PhD, FARVO, and David R. Williams, PhD, FARVO, are the vice presidents-elect who will serve during that term.

Dr. Smith is the Schnitzer Professor of Ophthalmic Research and an associate professor of ophthalmology and cell and developmental biology at the Casey Eye Institute, Oregon Health and Science University, Portland. Dr. Penn is the Phyllis G. and William B. Snyder Professor of Ophthalmology, director of research and vice chairman in the department of ophthalmology and visual sciences, and a professor of pharmacology and cell and developmental biology at Vanderbilt University School of Medicine, Nashville. Dr. Williams is the William G. Allyn Professor of Medical Optics, director of the Center for Visual Science, and a professor of brain and cognitive sciences, optics, ophthalmology, and biomedical engineering at University of Rochester in New York.

For more articles in this issue of Ophthalmology Times eReport, click here.